麻豆传媒

European registry analysis brings surprises along with the expected

Patient achieves remission with biologic agent currently used for myeloma

Records suggest guidelines on contraceptives are mostly not followed

But hint of benefit suggests the approach might not be a dead end

Spanish cohort study tracked patients for up to 20 years after diagnosis

This could exacerbate disease burden and reduce quality of life, researchers say

Blackness, per se, seen as less important than area socioeconomics

British data suggest how environmental and genetic factors add together

Sobering findings from Nurses' Health Study

Mid-stage trial tests a JAK inhibitor as monotherapy and in combination with a BTK blocker

Metformin benefits seen extending way beyond its glucose-lowering properties

Numbers of patients, length of follow-up keep growing with no visible downside (yet)

Health news and commentary gathered by 麻豆传媒 staff

Hint: it's not just the cumulative dose